Biliary Tract Neoplasms

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Suprapapillary Versus Transpapillary Plastic Stents for Unresectable Malignant Hilar Biliary Obstruction

Tucatinib Continuation Study

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice

An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract Malignancies

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Personalized Medicine for Advanced Biliary Cancer Patients

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Agnostic Therapy in Rare Solid Tumors

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers